Biochemical and functional studies on EMD 49 980: a potent, selectively presynaptic D-2 dopamine agonist with actions on serotonin systems

European Journal of Pharmacology

Volumn 160, Issue 1, 1989, Pages 31-41

  Seyfried, Christoph A ^a   Greiner, Hartmut E ^a   Haase, Anton F ^a  

^a MERCK KGAA   (Germany)

Author keywords

5 HT1A receptors; Acetylcholine; Dopamine receptors (presynaptic, postsynaptic); Indolybutylamines; Serotonin; Turning behavior

Indexed keywords

2 DIPROPYLAMINO 8 HYDROXYTETRALIN; ACETYLCHOLINE; APOMORPHINE; CHLORAMPHETAMINE; CHLORPROMAZINE; CLONIDINE; CLOZAPINE; DOPAMINE RECEPTOR; FLUOXETINE; GAMMA BUTYROLACTONE; IDAZOXAN; INDALPINE; OXIDOPAMINE; PERGOLIDE; POSTSYNAPTIC RECEPTOR; PRECLAMOL; PRESYNAPTIC RECEPTOR; RADIOISOTOPE; RESERPINE; ROXINDOLE; SEROTONIN; SEROTONIN 1A RECEPTOR; SEROTONIN RECEPTOR; TALIPEXOLE; 5 HYDROXYTRYPTOPHAN; DOPA; DOPAMINE DERIVATIVE; DOPAMINE RECEPTOR STIMULATING AGENT; INDOLE DERIVATIVE; P CHLOROAMPHETAMINE; PYRIDINE DERIVATIVE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; BRAIN; CIRCLING BEHAVIOR; CORPUS STRIATUM; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; ANIMAL; ARTICLE; BRAIN LEVEL; DRUG EFFECT; HIPPOCAMPUS; METABOLISM; PHYSIOLOGY; RAT STRAIN; SYNAPTOSOME;

4-BUTYROLACTONE; 5-HYDROXYTRYPTOPHAN; ACETYLCHOLINE; ANIMAL; BRAIN CHEMISTRY; DIHYDROXYPHENYLALANINE; DOPAMINE AGENTS; HIPPOCAMPUS; HYDROXYDOPAMINES; INDOLES; MALE; OXIDOPAMINE; P-CHLOROAMPHETAMINE; PYRIDINES; RATS; RATS, INBRED STRAINS; RESERPINE; SEROTONIN; SYNAPTOSOMES;

EID: 0024477447     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/0014-2999(89)90651-1     Document Type: Article

References (34)

1. Neurophysiological and behavioral studies of the effects of B-HT 920 and EMD 38 362 on dopamine autoreceptors and postsynaptic dopamine receptors
2. 3H-idazoxan in rat brain
3. Dopamine receptor agonists: intrinsic activity vs. state of receptor
4. Electrophysiological studies on EMD 23448, an indolyl-3-butylamine, in the rat: a putative selective dopamine autoreceptor agonist
5. Dopamine-receptor agonists: mechanisms underlying autoreceptor selectivity. I. Review of the evidence
6. Dopamine receptor agonists: mechanisms underlying autoreceptor selectivity. II. Theoretical considerations
7. Stimulation of presynaptic dopamine autoreceptors by 4-(2-di-n-propylaminoethyl)indole (DPAI)
8. 3H]5-methoxy-3-(di-n-propylamino)chroman
9. Biosynthesis of serotonin in raphe nuclei of rat brain: effect of p-chlorophenylalanine
10. p-Iodoamphetamine as a serotonin depletor in rats
11. Serotonin inhibits acetylcholine release from rat striatum slices: evidence for a presynaptic receptor-mediated effect
12. 3H-doPA in various regions of the brain
13. Postsynaptic dopamine (DA) receptor stimulator properties of the putative DA autoreceptor-selective agonist B-HT 920 uncovered by co-treatment with the D-1 agonist SKF 38393
14. In vivo biochemical characterisation of 8-OH-DPAT: evidence for 5-HT receptor selectivity and agonist action in the rat CNS
15. Studies on the receptor profile of bisoprolol
16. Dopamine agonist activity of EMD 23 448
17. Radiochemical assay of Ach: modifications for sub-picomole measurements
18. Receptor reserve at striatal dopamine autoreceptors: implications for selectivity of dopamine agonists
19. 1A receptor agonist 8-OH-DPAT on 5-HT release in vitro
20. Postsynaptic dopamine agonist properties of TL-99 are revealed by yohimbine co-treatment
21. 2-adrenergic antagonists with yohimbine and rauwolscine on monoamine synthesis in rat brain
22. Postsynaptic dopamine antagonist properties of B-HT 920 as revealed by concomitant D-1 receptor stimulation
23. Regional differences in receptor reserve for analogs of oxotremorine in vivo: implications for development of selective muscarinic agonists
24. Effect of dopamine agonists and neuroleptic agents on striatal acetylcholine transmission in the rat: evidence against dopamine receptor multiplicity
25. 3C-acetylcholine release by the putative dopamine autoreceptor agonist B-HT 920
26. An automated direct-injection HPLC-method for the electrochemical/fluorimetric quantitation of monoamines and related compounds optimized for the screening of large numbers of animals
27. Demonstration of a new type of dopamine receptor agonist: an indolyl-3-butylamine. Actions at intact versus supersensitive dopamine receptors in the rat forebrain
28. Neurochemical and functional studies with EMD 23 448, a novel dopamine agonist
29. Novel dopamine agonists of the indolylbutylamine type: preversus postsynaptic activity in various in vivo and in vitro models
30. High affinity choline uptake in striatum and hippocampus: differential effects of treatments which release acetylcholine
31. Behavioral studies of OPC-4392 a new neuroleptic agent
32. Quantitative recording of rotational behavior in rats after 6-hydroxy-dopamine lesions of the nigrostriatal dopamine system
33. The enantiomers of the D-2 dopamine receptor agonist N-0437 discriminate between pre- and postsynaptic dopamine receptors
34. Dopaminergic neurons: an in vivo system for measuring drug interactions with presynaptic receptors